Anika Therapeutics | ANIK - Ebitda





Ebitda تغيير تاريخ
Abbott USD 3.09B 44M 2025-09
Agenus USD -10.11M 19.02M 2025-03
Agios Pharmaceuticals USD -115.49M 10.3M 2025-09
Anika Therapeutics USD 4.54M 3.67M 2025-12
Arrowhead Research USD 64.2M 223.53M 2025-09
Halozyme Therapeutics USD 21.9M 226.34M 2025-12
Heron Therapeutics USD -3.88M 5.63M 2024-09
Insmed USD -314.19M 31.48M 2025-12
Integra LifeSciences USD 104.21M 25.76M 2025-12
Intrexon USD -24.7M 2.92M 2024-06
J&J USD 7.19B 2.32B 2025-12
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Ligand Pharmaceuticals USD 150.32M 129.42M 2025-09
MacroGenics USD 21.95M 55.39M 2025-09
Merit Medical Systems USD 97.23M 17.69M 2025-12
Rigel Pharmaceuticals USD -4.17M 798K 2023-09
Sanofi EUR 4.84B 2.95B 2025-09
Smith & Nephew USD 796M 139M 2025-12
Stryker USD 1.67B 206M 2025-09
Surmodics USD 3.43M 1.9M 2025-06
Veracyte USD 42.31M 2.58M 2025-12
Xencor USD -51.05M 55.28M 2025-12
Zimmer Biomet Holdings USD 759M 120.8M 2025-12